Chennai-based TTK Healthcare Ltd. has revised the buy back price for the proposed voluntary delisting of its shares from the foremost bourses. On Tuesday, the maker of Woodward’s Gripewater stated that it had revised the buy back price to ₹1,201.30 apiece in opposition to ₹1,051.31 fastened on April 19. Shares of the corporate gained ₹7.60, or 0.61%, to shut at ₹1,252 on the BSE on Tuesday. On April 5, the corporate stated that its promoters had proposed to purchase all of the fairness shares held by public shareholders and file for voluntary delisting from BSE and NSE.
